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The mechanisms underlying stem cell acquisition of a cardiac
phenotype are unresolved. We studied early events during the
acquisition of a cardiac phenotype by a cloned adult liver stem cell
line (WB F344) in a cardiac microenvironment. WB F344 cells
express a priori the transcription factors GATA4 and SRF, connexin
43 in the cell membrane, and myoinositol 1,4,5-triphosphate re-
ceptor in the perinuclear region. Functional cell–cell communica-
tion developed between WB F344 cells and adjacent cocultured
cardiomyocytes in 24 h. De novo cytoplasmic [Ca2]c and nuclear
[Ca2]nu oscillations appeared in WB F344 cells, synchronous with
[Ca2]i transients in adjacent cardiomyocytes. The [Ca2] oscilla-
tions in the WB F344 cells, but not those in the cardiomyocytes,
were eliminated by a gap junction uncoupler and reappeared with
its removal. By 24 h, WB F344 cells began expressing the cardiac
transcription factors Nkx2.5, Tbx5, and cofactor myocardin; cardiac
proteins 24 h later; and a sarcomeric pattern 4–6 days later.
Myoinositol 1,4,5-triphosphate receptor inhibition suppressed WB
F344 cell [Ca2]nu oscillations but not [Ca2]c oscillations, and
L-type calcium channel inhibition eliminated [Ca2] oscillations in
cardiomyocytes and WB F344 cells. The use of these inhibitors was
associated with a decrease in Nkx2.5, Tbx5, and myocardin expres-
sion in the WB F344 cells. Our findings suggest that signals from
cardiomyocytes diffuse through shared channels, inducing [Ca2]
oscillations in the WB F344 cells. We hypothesize that the WB F344
cell [Ca2]nu oscillations activate the expression of a cardiac spec-
ifying gene program, ushering in a cardiac phenotype.
calcium signal transduction  cardiomyogenesis  gap junctions
Extracardiac stem cell use in early phase clinical trials andanimal experiments has raised the possibility that stem cell
therapy may be able to repair the damaged heart (for review see
refs. 1 and 2). The mechanisms underlying the acquisition of a
cardiac phenotype by stem cells have not been elucidated. In
some cases, fusion between stem cells and cardiomyocytes has
been proposed as the basis for the apparent ‘‘transdifferentia-
tion’’ (3). We (4) and others (5, 6) have demonstrated that
extracardiac stem cells can acquire a cardiac phenotype when
placed in a cardiac microenvironment without the benefit of
fusion with surrounding myocytes.
We have found that cells from a stem cell line (WB F344)
derived from a cloned single nonparenchymal epithelial cell
isolated from the liver of a young adult rat (for review see ref.
7) respond in vivo (8) and in culture (4) to signals from a cardiac
microenvironment and acquire a cardiomyocyte phenotype.
Understanding the mechanisms that regulate the acquisition of
a cardiac phenotype by a clone-derived stem cell (for example,
WBF344 cells) may prove valuable in selecting andmanipulating
stem cells from other sources, e.g., autologous stem cells, and so
enhance their potential for successful use in cell therapy.
In the current study we examined the earliest events associated
with the acquisition of a cardiomyocyte phenotype by WB F344
cells cocultured with rat neonatal heart cells, a cardiac environ-
ment model system (4). We find that cell–cell communication
through shared and functional gap junction channels is estab-
lished between WB F344 cells and adjacent neonatal myocytes
as early as 24 h in coculture. This communication is associated
with novel cytoplasmic ([Ca2]c) and nuclear ([Ca2]nu) calcium
oscillations in the WB F344 cells that are synchronous with
[Ca2]i transients in juxtaposed myocytes. The [Ca2]nu oscilla-
tions require myoinositol 1,4,5-triphosphate receptor (IP3R)
stimulation and are associated with de novo expression of cardiac
transcription factors in the WB F344 cells. We hypothesize that
collectively these events usher in the acquisition of a cardiac
phenotype in the WB F344 stem cell line.
Results
Early Intercellular Communication Between Neonatal Myocytes and
WB F344 Cells. Because WB F344 cells express connexin 43
(Cx43), the predominant isoform expressed in ventricular myo-
cytes, we examined whether myocytes and WB F344 cells
develop shared Cx43-derived gap junctions. Twenty-four hours
after dsRed fluorescent WB F344 cells were cocultured with
heart cells, functional cell–cell communication between their
cytoplasm and juxtaposed neonatal cardiomyocytes was demon-
strated by fluorescence recovery after photobleaching (Fig. 1).
When in older cocultures (4–6 days old) WB F344 cells had
acquired a cardiac phenotype, Cx43 was preferentially localized
at the interface between neonatal cardiomyocytes and differen-
tiated WB F344-derived myocytes, as we previously reported (4)
[supporting information (SI) Fig. 7].
De Novo Calcium Oscillations in theWB F344 Cells. dsRed fluorescent
WB F344 cells were examined for [Ca2] signals 18–24 h after
their addition to primary neonatal rat heart cell cultures. [Ca2]c
oscillations were detected in the cytoplasm of approximately 1 in
20WBF344 cells that were adjacent to a neonatal cardiomyocyte
(Figs. 2 and 3A). The WB F344 cell [Ca2]c oscillations had the
same frequency but lower amplitude than [Ca2]i transients in
adjacent spontaneously contracting or paced cardiomyocytes
(Fig. 2). The calcium transients in the spontaneously beating
neonatal myocyte, measured at different distances from the cell
membrane, had the same kinetics and amplitude. This suggests
that calcium-induced calcium release is the mechanism under-
lying the calcium transients in these myocytes. In contrast, WB
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F344 cell [Ca2]c oscillation amplitude and rate of rise were
highest in the region where the WB F344 cell membrane was
closest to that of the cardiomyocyte and decreased with distance
away from the cardiomyocyte, suggesting a diffusion-mediated
calcium signal rather than calcium-induced calcium release (Fig.
2). WB F344 cells cultured alone or in coculture but distant from
cardiomyocytes did not demonstrate any [Ca2] oscillations or
change in phenotype, suggesting that a humoral factor released
into the culture medium did not induce these transformations.
After addition of the gap junction blocker carbenoxolone, the
WB F344 cell [Ca2]c signals were eliminated, whereas the
cardiomyocyte [Ca2]i transients were maintained. After car-
benoxolone removal, the WB F344 cell [Ca2]c oscillations
reappeared (Fig. 3B). The WB F344 cell nucleus makes up a
large portion of the cell volume. Nuclear [Ca2]nu oscillations
were detected in 1 in 40 WB F344 cells, usually when the
nucleus was no more than 2–3 m away from an adjacent
cardiomyocyte (Fig. 3A, line 2). The WB F344 cell [Ca2]nu
oscillations were most prominent in the perinuclear region and
had the same frequency as those in the cytoplasm (Fig. 3C).
In agreement with other investigators (9), we found using
immunocytochemistry that WB F344 cells express IP3R that is
preferentially localized in the perinuclear region and endoplas-
mic reticulum (Fig. 3D). The IP3R inhibitors, 2-aminoethoxy-
diphenyl borane (2-APB), used at 4 mol/liter, and xestospongin
C, used at 5 mol/liter (not shown), suppressed the nuclear
[Ca2]n oscillations in the WB F344 cells but not the cytoplasmic
[Ca2]c oscillations in either the WB F344 cells or the cardio-
myocytes (Fig. 3C). Nifedipine, an L-type calcium channel
antagonist, used at 1 mol/liter eliminated the cardiomyocyte
[Ca2]i transients and the WB F344 cell [Ca2]c and [Ca2]nu
oscillations (SI Fig. 8).
Acquisition of a Cardiac Phenotype.We examined the expression of
transcription factors that combine to specify a cardiac phenotype
(Nkx2.5, Tbx5, GATA4, SRF, myocardin, and Mef2c) (for
review see ref. 10) in dsRed fluorescent WB F344 cells that were
cultured alone and in coculture with heart cells. WB F344 cells
cultured with neonatal heart cells and harvested by FACS
demonstrated de novo expression of Nkx2.5, Tbx5, and myocar-
din, and up-regulation of Mef2c as early as 24 h after coculture
(Fig. 4). The expression of these transcription factors increased
further by 72 h (Fig. 4). The expression of GATA4 and SRF was
not changed (data not shown).
Expression at the RNA level of the cardiac specific proteins
cardiac troponin T (data not shown) and cardiac troponin I (data
not shown), and the cardiac L-type voltage-dependent calcium
channel (cVDCC) (Fig. 4), was detected in the WB F344 cells
48–72 h after the initiation of coculture. Four to 7 days later
some WB F344 cells adjacent to cardiomyocytes acquired a
cardiac phenotype, as previously described (4). They exhibited a
striated sarcomeric pattern that contained cardiac troponin T
(SI Fig. 9). In seeking further evidence of gene reprogramming
in WB F344 cells cocultured with neonatal cardiac cells, we
examined the expression of a stem cell marker (c-Kit, a stem cell
factor receptor) in WB F344 cells cultured alone or with
neonatal heart cells. This was compared with the expression of
cardiac myocyte proteins, the cVDCC, and the sarcomeric
proteins cardiac troponin T and cardiac troponin I. We found in
WB F344 cells cocultured with heart cells that c-Kit expression
decreased with time in culture as the expression of cVDCC
increased (Fig. 4).
Expression of Nkx2.5, Tbx5, and myocardin was significantly
decreased in the presence of the IP3R inhibitor 2-APB, used
Fig. 1. Gap junction-mediated cell–cell communication recorded in early
(24–48 h) WB F344/cardiomyocyte cocultures. (A and B) Calcein-labeled co-
culture with WB F344 cell 1 and cell 2 adjacent to cardiomyocytes before laser
excitation (A) and immediately after exposure to high-intensity laser excita-
tion (B). (C) Fluorescence recovery in WB F344 cell 1 through shared gap
junction channels with adjacent cardiomyocytes. It is presumed that WB F344
cell 2 was not functionally coupled with adjacent myocytes because no fluo-
rescence recovery was recorded. (D) Graph of fluorescence recovery vs. time in
WB F344 cell 1 and cell 2.
Fig. 2. Calcium signals acquired from undifferentiated WB F344 cells and
adjacent cardiomyocytes. (Upper) Image of dsRed WB F344 cell adjacent to
cardiomyocyte in coculture labeled with fluo-4 AM. Confocal line scan micros-
copy was used to record intracellular calcium oscillations along the dotted
line. (Lower) Tracings correspond to the areas marked by the color-coded dots
in the line scan. Shown are signal-averaged calcium signals at the immediate
cardiomyocyte (green)/WB F344 cell (red) interface, 4 m away from the cell
interface in the WB F344 cell (blue), and 4 m away from the interface in the
cardiomyocyte (black). Decreased amplitude of the [Ca2] signal is demon-
strated in the WB F344 cell with distance from the cell interface (red and blue
lines) suggesting a diffusion-mediated signal but not in the cardiomyocyte
(green and black lines), where a uniform [Ca2]i within the cardiomyocyte is
believed to be mediated by a calcium-induced calcium release process. The
calcium oscillations in the WB F344 cells depend on direct contact between the
WB F344 cells and adjacent myocytes. WB F344 cells cultured alone or distant
from cardiomyocytes did not demonstrate oscillations even when paced,
suggesting that a humoral factor secreted into the medium did not induce
these oscillations. (Scale bar: 10 m.)
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overnight in the culture medium at 4 mol/liter (Fig. 5). This
inhibitor suppressed the WB F344 cell [Ca2]nu oscillations (Fig.
3C). The expression of Nkx2.5, Tbx5, and myocardin was sig-
nificantly decreased in the presence of the L-type calcium
channel blocker nifedipine, used overnight in the culture me-
dium (Fig. 5). Nifedipine inhibition did not persist as some
myocytes were still contracting after exposure to 4 mol/liter
nifedipine overnight.
The FACS-harvested dsRed fluorescent WB F344 cells con-
tained a mixed population of WB F344 cells; a small population
of WB F344 cells that had formed couplings with myocytes and
a majority of WB F344 cells that were seeded either next to
nonmyocyte heart cells or away from cardiomyocytes. This
majority of WB F344 cells proliferated and formed nests of cells
with a typical WB F344 cell phenotype. With time in culture,
these proliferating WB F344 cells became an increasingly larger
proportion of the WB F344 cell population, decreasing the
relative number of FACS-harvested WB F344 cells that were
responding to signals from adjacent myocytes.
We examined in a sorted FACS dsRed fluorescent WB F344
cell population the extent of contamination with neonatal heart
cells using postsort assessments and found that contamination
was 1%. This is consistent with the PCR analysis of microsat-
ellite DNA where we exploited the strain-specific allelic differ-
ences in DNA microsatellite markers between Sprague–Dawley
neonatal rat heart cells and WB F344 cells cloned from an
American Fischer 344 (F344) rat. No Sprague–Dawley micro-
satellite DNA was detected in PCR amplicons from the dsRed
fluorescent WB F344 cell population harvested from cocultures
with neonatal heart cells (Fig. 6). In control experiments, we
were able to detect to10% contamination by Sprague–Dawley
cells in a Fischer cell population. These results also suggest that,
if fusion occurred between the Fischer WB F344-derived cells
and the surrounding Sprague–Dawley heart cells, this event was
infrequent.
Discussion
Overview. We demonstrate in WB F344 cell/neonatal heart cell
cocultures that a signal is transmitted from the cardiomyocytes
into juxtaposed WB F344 cells through shared functioning,
Fig. 3. Inhibition of calcium signals acquired from undifferentiated WB F344
cells cocultured with cardiomyocytes. (A) Representative image of undiffer-
entiated WB F344 cell adjacent to cardiomyocyte in coculture. Cardiomyocyte
[Ca2]i transients and adjacent WB F344 cell [Ca2]c oscillations or cardiomy-
ocyte [Ca2]i transients and adjacent WB F344 cell [Ca2]n oscillations were
acquired by line scan confocal microscopy in the region along dotted line 1 or
line 2, respectively. (B) WB F344 cell [Ca2]c oscillations (red) were synchronous
with the cardiomyocyte [Ca2]i transients (green) during control conditions.
The line scan was recorded from an area that corresponds to the dotted line
1 in A. WB F344 cell [Ca2]c oscillations were abolished in the presence of the
gap junction uncoupler carbenoxolone, whereas the cardiomyocyte [Ca2]i
transients were maintained. Approximately 30 min after the carbenoxolone
was washed out of the culture medium, the WB F344 cell [Ca2]c oscillations
were restored. (C) Inhibition of WB F344 cell [Ca2]nu oscillations. Cytoplasmic
[Ca2]c (red) and nuclear [Ca2]nu (black) signals were recorded in a WB F344
cell in coculture before and after the addition of the IP3R inhibitor 2-APB. The
tracings represent calcium signals recorded from a WB F344 cell nuclear region
that corresponds to dotted line 2 inA. The WB F344 cell [Ca2]nu signals (black)
were significantly suppressed in the presence of the IP3R inhibitor. (D) IP3R
was localized by immunocytochemistry to the perinuclear region (white arrow
and green fluorescence in D) and the endoplasmic reticulum (red arrows) of
WB F344 cells. D is a merged image of FITC fluorescence and DAPI nuclear
counterstain (63 oil immersion objective lens).
Fig. 4. RNA levels (expressed as fold change) of cardiac transcription factors,
Nkx2.5, Tbx5, myocardin, and Mef2c, WB F344 cells cultured alone (column A),
WB F344 cells cocultured with heart cells for 18–48 h (column B), WB F344 cells
cocultured with heart cells for 48–72 h (column C), and cardiac cells cultured
alone (column D). Gene reprogramming is noted by the decrease in expression
of c-Kit and the increase in expression of the cVDCC with time in culture in the
same conditions. The bars show mean  SEM. *, P  0.001. (See primer
sequences in SI Table 1.)
Muller-Borer et al. PNAS  March 6, 2007  vol. 104  no. 10  3879
D
EV
EL
O
PM
EN
TA
L
BI
O
LO
G
Y
presumably Cx43-derived gap junction channels. This signal
induces in the WB F344 cell ‘‘cardiac-like’’ calcium oscillations
that have the same frequency as the calcium transients in
adjacent cardiomyocytes. The WB F344 cell calcium oscillations
are detected in the cytoplasm ([Ca2]c) and the perinuclear
region ([Ca2]nu). The [Ca2]nu signals appeared to be the
product of IP3R stimulation and to be associated with the
expression of cardiac transcription factors Nkx2.5, Tbx5, and
the cofactor myocardin and up-regulation ofMef2c because both
the [Ca2]nu oscillations and the de novo expression of the
cardiac transcription factors were suppressed with use of IP3R
inhibitors. We hypothesize that these mechanisms contribute,
together with prior expression of SRF and GATA4 in the WB
F344 cells, to their acquisition of a cardiac phenotype.
Our finding of calcium oscillations in the WB F344 cells early
after coculture is consistent with previous investigations in early
ES cell-derived cardiomyocytes (11). [Ca2]i oscillations were
found to be present in ES cells independent of their expression
of a cVDCC or ryanodine-sensitive Ca2 release channel.
WB F344 cells in monoculture do not express the cVDCC but
begin to express an increasing amount of cVDCC, as some
acquire a cardiac phenotype in coculture (Fig. 4). That the
calcium oscillations in the WB F344 cells are lost when carben-
oxolone, a gap junction uncoupler, is introduced into the me-
dium and are re-acquired with its removal, whereas nifedipine
acutely eliminated the calcium transient in the cardiomyocyte
and in the WB F344 cell, lead us to conclude that the early
calcium oscillations in the WB F344 cells before they acquire a
cardiac phenotype are dependent on cardiomyocyte excitation
and cell–cell communication between the cardiomyocytes and
the WB F344 cells.
Calcium Signaling. Evidence that calcium signals trigger transcrip-
tional responses is mounting (12–26). Calcium-driven transcrip-
tion of cell-specific genes has been described in lymphocytes (15,
16), neuronal cells (17), smoothmuscle cells (18), skeletal muscle
(19), and cardiomyocytes (14, 20, 21). In the heart, transcription
under physiological conditions is believed to be ‘‘under a con-
stant Ca2-dependent surveillance’’ (14). Calcium sensing cas-
cades through calmodulin and its downstream effectors, CaMK
(22) and calcineurin (15), PKC (23), and Ras (24) have been
reported to transduce calcium signals into transcriptional re-
sponses specific for each cell type. Furthermore, it has been
suggested that the diversity in gene transcription responses
depends on the amplitude, frequency, and duration of the
calcium signal and its spatiotemporal properties (12, 22, 25, 26).
Oscillating nuclear calcium signals have been reported to in-
crease the efficiency and specificity of gene transcription (25, 26)
and are believed to regulate the expression of transcription
Fig. 5. Suppression of cardiac transcription factor expression with inhibitors.
Expression (noted in fold change) of the cardiac transcription factors Nkx2.5,
Tbx5, and myocardin in WB F344 cells cultured alone (column A), WB F344 cells
cocultured with heart cells for 18–24 h (column B), WB F344 cells cocultured
with heart cells in the presence of the IP3R inhibitor 2-APB for 18–24 h (column
C), and WB F344 cells cocultured with heart cells in the presence of the cVDCC
inhibitor nifedipine for 18–24 h (column D). The bars show mean SEM. *, P
0.001.
Fig. 6. Polymorphic microsatellite markers. By using the D9U1A7 set of
microsatellite markers, the amplicons from the control or FACS-harvested
Fischer WB F344 cells DNA (lanes 4 and 5) are shifted down compared with the
PCR product from control Sprague–Dawley DNA (lane 3, white asterisks in
Top). Lane 1, DNA ladder; lane 2, no DNA control. By using a second set of
markers, D17U1A2, three amplicons (white asterisks in Middle) are present
only in the Sprague–Dawley control DNA (lane 3) but not in the harvested WB
F344 cells. By using a third set of markers, D1U1A14, the amplicons from the
Fischer WB F344 DNA (lanes 4 and 5) are shifted up compared with the PCR
product from the Sprague–Dawley DNA (white asterisks in Bottom). (See
primer sequences in SI Table 2.)
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factors that are different from factors regulated by cytoplasmic
calcium signals (27–29). Nuclear calcium signals are suspected to
be triggered by the release of calcium from the nuclear envelope
calcium stores through nuclear membrane IP3R stimulation (21,
30). As we demonstrate here and as previously reported by other
investigators (9), WB F344 cells express IP3R localized to the
perinuclear region. The IP3R inhibitor suppressed the [Ca2]nu
signals in the WB F344 cells and were associated with a
significant decrease in expression of the cardiac transcription
factors, Nkx2.5, Tbx5, and myocardin, suggesting that at this
early stage the process may be reversible. These findings lead us
to hypothesize that cardiac-like [Ca2]nu oscillations in the WB
F344 cell have a role in triggering the expression of a cardiac
specifying gene program that results in their acquisition of a
cardiac phenotype.
Cell Coupling. We (4) and others (6, 31, 32) have found that stem
cell expression of Cx43 and their close proximity with cardio-
myocytes may be important in the stem cell acquiring a cardiac
phenotype in culture. Cx43-derived gap junctions have been
reported to be permeable to small molecules such as IP3 and
calcium ions (for review see ref. 33). Because the IP3R inhibi-
tors, xestospongin C and 2-APB, did not eliminate [Ca2]c
oscillations in the WB F344 cells, we suggest that these oscilla-
tions were not the result of IP3 triggering release of calcium from
theWB F344 cell cytoplasmic stores. Rather another mechanism
such as calcium ions diffusing from the myocyte through shared
gap junction channels may have taken place. Our finding that the
WB F344 cell [Ca2]c oscillations decrease in amplitude with
distance from the juxtaposed cardiomyocyte, potentially the
product of a calcium-diffusion coefficient, is consistent with this
interpretation. In contrast, we find that the nuclear [Ca2]nu
oscillations in the WB F344 cells are dependent on IP3R activity
in the perinuclear region.
Functional Cx43-derived gap junctions between stem cells and
adjacent myocytes appear to provide a conduit through which
the stem cell receives signals from the myocyte. We suggest that
Cx43 expression is one of the important criteria to be used in the
selection of stem cells for potential therapy in the heart. In
agreement with our results, stem cells known to develop ana-
tomical couplings with myocytes and to express Cx43 (31) such
as mesenchymal stem cells (6, 32) have been demonstrated to
acquire a well differentiated cardiac phenotype. Failure to
express Cx43 may underlie the potential life-threatening dys-
rhythmias observed when other types of stem cells, such as
skeletal myoblasts, have been used in stem cell therapy in the
heart (2). Cell–cell communication that allows electrical cou-
pling between the donor stem cell-derived cardiomyocyte and
the recipient cardiomyocyte appear to be an important criterion
for successful stem cell treatment of the patient with a failing
heart.
Materials and Methods
Cell Cultures and Genetic Modification of WB F344. WB F344 cells
and 1-day-old neonatal Sprague–Dawley rat ventricular cells
were cocultured as previously described (4). WB F344 cells were
transfected with a plasmid that encodes a dsRed fluorescent
protein targeted to the mitochondria following the vendor’s
specifications (BD Biosciences Clontech Laboratories, Palo
Alto, CA). They were seeded with neonatal heart cells at a ratio
of 1/10 to 1/100 and maintained in culture up to 6 days.
Fluorescence Recovery After Photobleaching. Fluorescence recov-
ery after photobleaching measured cell–cell communication via
functional gap junction channels between dsRed fluorescentWB
F344 cells, cultured alone or with heart cells. All cells were
intracellularly labeled with the fluoroprobe calcein AM, as
previously described (4). Clean diffusion through functional gap
junctions into the cytoplasm of a bleachedWB F344 cell from an
adjacent unbleached cardiomyocyte was recorded for 10 min at
30- to 120-sec intervals.
Confocal Imaging of Calcium Signals. dsRed fluorescent WB F344
cells, cultured alone or in coculture with heart cells, were
incubated in the calcium sensitive fluoroprobe, f luo-4 AM (5
mol/liter; Molecular Probes, Eugene, OR) for 30 min at 20°C
and subsequently washed several times with dye-free, phenol-red
free Richter’s medium plus 2% horse serum before measure-
ments were recorded.
Confocal f luorescence images were acquired to record cell
position, alignment, and geometry with a LSM510 inverted
laser-scanning confocal microscope with high-resolution optics
(63/1.4 N.A. oil immersion objective and environmental cham-
ber; Carl Zeiss Microimaging, Thornwood, NY). The line scan
mode with an excitation wavelength of 488 nm and an emission
filter wavelength of 515  15 nm were used for quantitative
analysis of [Ca2] signals. A line spanning a neonatal cardiomy-
ocyte and an adjacent WB F344 cell was defined, and fluores-
cence emission was collected at a rate of 1.92 ms per 1,024-pixel
line. In separate experiments, a line was selected that also
spanned cardiomyocyte and the adjacent WB F344 cell and its
nucleus (Fig. 3A, line 2). The cardiomyocytes beat spontaneously
or were electrically stimulated with a platinum bipolar electrode,
using rectangular pulses, 1 ms in duration, 2 threshold voltage,
1 Hz (Grass Instruments, Quincy, MA). The resulting time series
images were analyzed with Image J software. Fluorescence
signals were normalized by dividing the cell f luorescence (F) by
cell f luorescence recorded before stimulation/contraction (Fo).
The effect of inhibiting cell–cell gap junction coupling on the
[Ca2] signals was examined by using the reversible gap junction
uncoupler, carbenoxolone (3-hydroxy-11-oxoolean-12-en-30-
oic acid 3-hemisuccinate; Sigma–Aldrich, St. Louis, MO). In-
tracellular calcium signals were recorded at 10 and 30 min after
100 mol/liter carbenoxolone was added to culture medium and
30 min after the carbenoxolone was washed out. In separate
conditions, the cocultures were exposed to the IP3R inhibitors,
2-APB (Tocris, Ellisville, MO) at 4 mol/liter or xestospongin C
(Sigma–Aldrich) used at 5 mol/liter and to the L-type calcium
channel antagonist nifedipine (Sigma–Aldrich) used at 1 mol/
liter. The effect of these inhibitors on WB F344 cell [Ca2]c and
[Ca2]nu oscillations was examined before and after the addition
of these inhibitors.
PCR Amplification. dsRed fluorescent WB F344 cells were har-
vested from cocultures on days 1–3 by using a FACScan flow
cytometer (Becton Dickinson, Franklin Lakes, NJ) equipped
with a 70- or 100-m nozzle, a 488-nm argon laser for excitation
of the dsRed protein, and a 530  15-nm bandpass filter for
monitoring fluorescent emission. Postsort assessments examined
the extent of contamination of the sorted fluorescent WB F344
cell population by nonfluorescent neonatal cardiac cells.
Real-time RT-PCR was carried out, as previously described
(34) (see SI Table 1 for primer and probe sequences), in triplicate
on RNA isolated from WB F344 cells cultured alone and from
WB F344 cells cocultured with neonatal heart cells in the
absence or presence of 2-APB (4 mol/liter) or nifedipine (4
mol/liter) for 18–24 h. The expression of the cardiac specifying
transcription factors Nkx2.5, Tbx5, GATA4, SRF, the cofactor
myocardin and Mef2c, the cardiac proteins cardiac troponin T
and cardiac troponin I, and the cVDCC was examined over time
in culture. The expression of the stem cell marker c-Kit was
examined in WB F344 cells before and after coculture with
neonatal heart cells.
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Fischer Versus Sprague–Dawley GenomicMicrosatellite Amplification.
TheWBF344 cell line was isolated and cloned from anAmerican
Fischer 344 (F344) rat, and the neonatal cardiomyocytes were
harvested from Sprague–Dawley rats. Genomic DNA microsat-
ellite markers (primer sequences in SI Table 2) were amplified
by PCR, and the purity of the dsRed fluorescent WB F344 cell
population harvested by FACS from cocultures with neonatal
cardiomyocytes was examined. PCRs were run in easy-start PCR
tubes (Molecular BioProducts, San Diego, CA) by using the
manufacturer’s protocol and 70 ng of genomic DNA template, an
annealing temperature of 55°C, and 40 cycles of amplification in
a total volume of 20 l. The product was analyzed on 8%
polyacrylamide (30% acrylamide: 0.8% Bis-acrylamide, Ultra
Pure Protogel; National Diagnostics, Atlanta, GA) at 100 V for
4 h. Ethidium bromide staining and visualization on a UV
Transilluminator revealed whether or not samples contained
chimeric amplicon patterns (Fig. 6). We tested our ability to
detect contamination in WB F344 cell populations with Spra-
gue–Dawley cells by mixing different proportions of the two cell
populations and by using the microsatellite markers to distin-
guish between the two cell types through a distinct PCR ampli-
con pattern (data not shown). This analysis was furthermore
used to evaluate the presence and extent of cell and/or nuclear
fusion between the Fischer-derivedWB F344 cells and Sprague–
Dawley neonatal heart cells.
Immunocytochemistry. dsRed fluorescent WB F344 cells were
cocultured with neonatal heart cells on laminin-coated coverslips.
Immunocytochemistry was done as previously described (4). We
investigated the expression and localization of IP3R in theWBF344
cells using an IP3Rantibody that recognizes all three IP3R isoforms
(Chemicon, Temecula, CA). FITC-labeled anti-rabbit antibody was
used as the secondary antibody (Rockland Immunochemicals,
Gilbertville, PA). All immunoreactions were run in parallel without
primary antibody as controls for background staining. DAPI was
used as the nuclear counterstain. Immunofluorescent signals were
observed by using a Zeiss LSM5 Pascal Confocal Laser Scanning
Microscope equipped with argon laser, HeNe lasers, and a63 oil
immersion objective.
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